Canada Pension Plan Investment Board’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$590K Sell
29,411
-2,700
-8% -$63.1K ﹤0.01% 1186
2025
Q4
$988K Buy
32,111
+2,700
+9% +$60.4K ﹤0.01% 1069
2025
Q3
$478K Hold
29,411
﹤0.01% 1044
2025
Q2
$260K Sell
29,411
-1
-0% -$9 ﹤0.01% 1079
2025
Q1
$316K Hold
29,412
﹤0.01% 1003
2024
Q4
$376K Hold
29,412
﹤0.01% 1117
2024
Q3
$812K Hold
29,412
﹤0.01% 1008
2024
Q2
$853K Hold
29,412
﹤0.01% 1017
2024
Q1
$1.31M Hold
29,412
﹤0.01% 973
2023
Q4
$1.14M Hold
29,412
﹤0.01% 935
2023
Q3
$865K Hold
29,412
﹤0.01% 879
2023
Q2
$1.87M Hold
29,412
﹤0.01% 735
2023
Q1
$1.39M Hold
29,412
﹤0.01% 838
2022
Q4
$2.04M Hold
29,412
﹤0.01% 719
2022
Q3
$4.31M Hold
29,412
0.01% 544
2022
Q2
$3.83M Hold
29,412
0.01% 577
2022
Q1
$2.97M Hold
29,412
﹤0.01% 688
2021
Q4
$4.55M Hold
29,412
﹤0.01% 723
2021
Q3
$8.71M Hold
29,412
0.01% 597
2021
Q2
$9.55M Buy
+29,412
New +$9.65M 0.01% 543

Other funds holding LYEL

Canada Pension Plan Investment Board's LYEL Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Lyell Immunopharma (LYEL) stake by 8.4% in Q1 2026, selling an estimated $63.1K and leaving 29,411 shares worth $590K. The position accounts for ﹤0.01% of the portfolio, ranked #1186.

Canada Pension Plan Investment Board first reported a position in LYEL in Q2 2021 and has held it in 20 quarters since. The position peaked at $9.55M in Q2 2021. 74 funds tracked by Wall St. Rank hold LYEL as of Q1 2026.

  • Canada Pension Plan Investment Board held 29,411 shares of Lyell Immunopharma worth $590K as of Q1 2026.
  • Canada Pension Plan Investment Board sold 2,700 Lyell Immunopharma shares in Q1 2026, an estimated $63.1K.
  • Lyell Immunopharma made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1186 holding.
  • Canada Pension Plan Investment Board first reported a position in Lyell Immunopharma in Q2 2021 and has held it in 20 quarters since.
  • Canada Pension Plan Investment Board's Lyell Immunopharma position peaked at $9.55M in Q2 2021.
  • 74 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.